Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

HedgePath Pharmaceuticals Inc


Ticker Change

Company Profile for HedgePath Pharmaceuticals Inc (CBTEQ)

HedgePath Pharmaceuticals Inc is a development stage pharmaceutical company. The Company acquires technologies and intellectual properties related to the development of the drug itraconazole for the treatment of cancer.

Contact Information

HedgePath Pharmaceuticals Inc

324 South Hyde Park Avenue
Suite 350
Tampa, FL 33606
United States
Phone: 1-813-864-2559

Key Executives for HedgePath Pharmaceuticals Inc (CBTEQ)

Francis E O'Donnell JrChairmanNicholas Jon VircaPresident/CEO
Garrison J HasaraCFO/TreasurerJames A McNultySecretary/Compliance Officer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil